A Study of Luspatercept in People With Anemia
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT07725497
- Phase
- PHASE2
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Luspatercept — DRUGLuspatercept subcutaneous injection once every 3 weeks
Study Details
The researchers are doing this study to test whether luspatercept works to improve hemoglobin levels in people with anemia caused by chronic kidney disease (CKD). The researchers will also test whether luspatercept is a safe treatment that causes few or mild side effects in participants.
Key Dates
- First listed
- Jul 24, 2026
- Start date
- Jul 20, 2026
- Status verified
- Jul 2026
- Primary completion
- Jul 31, 2029
- Completion
- Jul 31, 2029
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: LuspaterceptLuspatercept subcutaneous injection once every 3 weeks
Primary Outcome Measure
Hemoglobin (HB) improvement [ Time Frame: within 12 weeks ]
Central Contacts
- Jodi Mones, MD646-608-3722
- Jeffrey Zwicker, MD646-608-3723
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) | Basking Ridge | New Jersey | 07920 | Jodi Mones, MD 646-608-3722 |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Middletown | New Jersey | 07748 | Jodi Mones, MD 646-608-3722 |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale | New Jersey | 07645 | Jodi Mones, MD 646-608-3722 |
| Memorial Sloan Kettering at Suffolk - Commack (Limited Protocol Activities) | Commack | New York | 11725 | Jodi Mones, MD 646-608-3722 |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison | New York | 10604 | Jodi Mones, MD 646-608-3722 |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | Jodi Mones, MD 646-608-3722 Jeffrey Zwicker, MD 646-608-3723 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Uniondale | New York | 11553 | Jodi Mones, MD 646-608-3722 |
Find similar trials in Basking Ridge, NJ
By condition
By specialty
By research site
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (Limited Protocol Activities)· Middletown, NJMemorial Sloan Kettering Bergen (Limited Protocol Activities)· Montvale, NJMemorial Sloan Kettering at Suffolk - Commack (Limited Protocol Activities)· Commack, NYMemorial Sloan Kettering Westchester (Limited Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center· New York, NY
Related Studies
- Diamond Blackfan Anemia Registry (DBAR)Recruiting · Northwell Health · New Hyde Park, New York
- Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening AnemiaEnrolling By Invitation · Englewood Hospital and Medical Center · Englewood, New Jersey
- A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on HemodialysisPHASE3 · Recruiting · Amgen · Los Angeles, California
- Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaPHASE1/PHASE2 · Recruiting · Disc Medicine, Inc · Gilbert, Arizona